Lecture 6.1 Flashcards

1
Q

Describe the normal development of the lungs

A

1) During embryogenesis, the respiratory system grows out from the ventral wall of the foregut
2) Midline trachea develops into lung buds
3) R lung bud divides into three main bronchi and the L into two > hence 3 Right lobes and 2 Left
4) Main bronchi continue to bifurcate into smaller and smaller airways, eventually dubbed “bronchioles” which have lost their cartilage and submucosal glands
5) These lead to “terminal bronchioles”
-The most distal part of these is called an “acinus” and these are composed of alveolar ducts and sacs
6) Of course, it is in the capillaries surrounding alveoli that respiratory gasses are exchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Atelectasis:
1) Define it
2) What does it result in?
3) What is the basic principle?

A

1) Also known as “collapse,” this should not be confused with pneumothorax
2) Loss of lung volume caused by inadequate expansion of airspaces
3) “Use it or loose it”
-After the precipitating factor of atelectasis, physiologic “shunting” of blood occurs
-Blood moves from poorly perfused areas with inadequate gas exchange to elsewhere
-The alveoli, in turn, begin to close

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define ARDS

A

“Respiratory failure occurring within 1 week of known clinical insult with bilateral opacities on chest imaging that is not fully explained by effusions, atelectasis, cardiac failure, fluid overload”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ARDS:
1) How can it occur?
2) What is it associated with?
3) What are the MC triggers?

A

1) In several different clinical settings
2) Primary pulmonary diseases and severe systemic inflammatory disorders: aka sepsis
3) PNA 35%-45%; Sepsis 30%-35%; Aspiration, trauma, pancreatitis, transfusion reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Differentiate between restrictive and obstructive Dz

A

1) Obstructive: characterized by increase in resistance to air flow – measured by difficulty blowing out
2) Restrictive: characterized by reduced expansion of lung and decreased total lung capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The four main types of obstructive disease are what? Describe each briefly

A

1) Emphysema: alveolar wall destruction, overinflation
2) Chronic bronchitis: productive cough, airway inflammation
3) Asthma: reversible obstruction; bronchial hyperresponsiveness with a trigger
4) Bronchiectasis: involves scarring of the airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Emphysema:
1) Define it
2) What are the 2 types?

A

1) Permanent enlargement of air spaces distal to terminal bronchioles (the acinus) with permanent destruction of their walls and significant fibrosis
2) Centriacinar and panacinar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Emphysema:
1) Which is the one smokers get? What is affected in this type?
2) Describe the second type of emphysema. When does it occur?

A

1) In centriacinar emphysema the central or proximal parts of acini are affected, and distal alveoli are spared
-This is the one smokers get
2) In panacinar emphysema the acini are uniformly enlarged
This occurs with alpha-1 antitrypsin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you get emphysema from alpha-1 antitrypsin?

A

1) Genetic disease affecting the lungs and liver
2) In the lung, alpha-1 antitrypsin is underproduced
- it is therefore unable to inhibit elastase
- elastase breaks down elastin in the lung
- acinus is affected as in normal emphysema – (but panacinar)
- obstructive disease
* homozygous disease more severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does Alpha-1 antitrypsin do?

A

Usually present in serum, tissue fluids, macrophages: it inhibits elastase, which breaks down elastin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Emphysema:
1) What is the primary Sx?
2) What compensates it? What does this lead to?
3) What do you see on PE?

A

1) Dyspnea
2) Hyperventilation, which leads to increased energy demands and weight loss that is often profound
-Caloric intake is also sometimes reduced
3) Tachypnea, pursed-lip breathing, hunched posture, barrel chest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 3 secondary effects of emphysema? Describe each

A

1) Pulmonary hypertension: Physiologic Shunting
2) Obstructive overinflation: Expansion of the lung due to air trapping
3) Bullae: Large, empty spaces in the lung where tissue is completely lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic Bronchitis:
1) In early stages, cough raises mucoid sputum, but airflow is not yet obstructed; what does this look like?
2) From there, the course is variable, but late-stage findings include what?

A

1) pts may have hyperreactive airways, though, that lead to intermittent bronchospasm and wheezing
2) Significant outflow obstruction: Hypercapnia, hypoxemia, cyanosis
-Pulmonary hypertension > you know where this leads. . .
COPD pts. with bronchitis often have more rapid disease progression with poorer outcomes than the isolated emphysema type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define asthma

A

“Chronic inflammatory disorder marked by intermittent, reversible airway obstruction, chronic bronchial inflammation with eosinophils, bronchial smooth muscle hypertrophy and hyperreactivity”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 2 types of asthma?

A

Atopic – hypersensitivity type I
Non atopic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Non-atopic asthma:
1) What would allergen skin test results be?
2) What may trigger attacks?
3) How does the Tx differ from atopic?

A

1) Do not have evidence of allergen sensitization and thus allergen skin tests for offending agent are usually negative
2) Attacks may still be triggered by viral illness and air pollutants
3) Many of the inflammatory mediators are the same and the treatment does not vary from atopic
Less often any family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

These patients have recurrent episodes of wheezing, breathlessness, chest tightness and cough particularly when?

A

At night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

1) What are some triggers of asthma attacks?
2) What abt specifically in the atopic type?

A

1) Most commonly viral illness, but often smoke, fumes, cold air, stress, exercise
2) Triggers may also include pollen, dust, animal dander, food
Onset of asthma attack may be preceded by rhinitis, urticaria, eczema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Asthma Tx involves direct response to the processes discussed. Explain what the 3 main options are.

A

1) Bronchodilators > beta-adrenergic drugs
2) Anti-inflammatory > steroids
3) Leukotriene inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Bronchiectasis:
1) Describe the cough and sputum
2) When do the Sx occur?

A

1) Severe persistent cough
Expectoration of copious sputum
Sometimes fetid and mucopurulent
2) Intermittent sx, correlate with new infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe a typical Idiopathic Pulmonary Fibrosis Patient and what their CT scan would look like

A

1) Older
2) Male
3) Chronic, nonproductive cough
4) “Dry” crackles on inspiration
5) Late stage cor pulmonale
6) “Honeycombing” on CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

List and describe 2 rare fibrosing diseases

A

1) Nonspecific interstitial pneumonia: Less severe than IPF
2) Cryptogenic organizing PNA: Severe disease that sometimes resolves spontaneously

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pneumoconiosis General Pathology:
1) What particulate is trapped? Where?
2) What accumulates? What does this initiate? Describe the response

A

1) 1-5 micrometer particulate is trapped in distal lung in alveolar duct bifurcations
2) Macrophages accumulate and engulf trapped particles
-Inflammatory response initiated  fibroblasts proliferate
-cells drain to lymphatics and amplify immune response through adaptive system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Coal Worker’s Pneumoconiosis (Anthracosis):
1) What does illness depend on? Why?
2) What is occurring in the body?

A

1) The extent of damage; coal is inert and so can rest in the lung a long time, building up large amounts before having an effect
2) Macrophages engulf carbon pigment and accumulate in connective tissue along pulmonary and pleural lymphatics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Coal Worker’s Pneumoconiosis (Anthracosis): differentiate between the simple and complicated types

A

1) Simple: Marked by “coal macules” and “coal nodules”
-Once lower lobes are heavily involved these pts develop emphysema
-Fibrotic element can progress to “progressive massive fibrosis” or “complicated CWP”
2) Complicated: Simple CWP + multiple, dark black scars, between 2-10 cm in length
-Continues to worsen even after no more exposure
-Pulmonary HTN; cor pulmonale

26
Q

1) Most prevalent chronic occupational disease in the world is what? Why?
2) What is occurring in the body w this disease?

A

1) Silocosis; Sandblasting and hard-rock mining
-Quartz, crisobalite, tridymite
2) Deposition in epithelial cells  fibrosis  “PMF” (progresisive massive fibrosis)  pulmonary HTN, cor pulmonale

27
Q

Asbestosis:
1) What causes it?
2) What condition does it lead to?
3) What is a key feature from occupational medicine?

A

1) Fibers deposited in lung  eaten by macrophages  inflammation/ fibrosis  “diffuse pulmonary interstitial fibrosis with ‘asbestos bodies’”
2) Mesothelioma
3) Families of workers are also exposed

28
Q

Asbestosis: Pt’s develop worsening dyspnea 10-20 years after exposure, describe why

A

1) Parenchymal interstitial fibrosis
2) Localized fibrous plaques
3) Pleural effusions
4) Lung carcinoma
5) Malignant pleural and peritoneal mesothelioma
6) Laryngeal carcinoma
*Risk of cancer goes way up if they are also smoking

29
Q

Hypersensitivity Pneumonitis:
1) What mediates it and what does it primarily effect?
2) What is it usually caused by?

A

1) Immunologically mediated lung disease that primarily affects the alveoli (allergic alveolitis)
2) Occupational exposure and heightened sensitivity to inhaled antigens
-pigeons, hot tubs, random things, etc

30
Q

Pulmonary embolus:
1) Almost all large pulmonary artery thrombi are what in origin? From where?
2) What are risk factors?

A

1) Embolic in origin, usually arising from the deep veins of the lower leg
2) Prolonged bed rest, knee or hip surgery, severe trauma, use of oral contraceptives (especially those with high estrogen content), disseminated cancer, and genetic causes of hypercoagulability.

31
Q

Pulmonary embolus:
1) What do most emboli cause? Explain
2) Is there a risk for recurrence?

A

1) Most emboli (60% to 80%) are clinically silent; a minority (5%, typically large “saddle emboli”) cause acute right-sided heart failure, shock, or sudden death; and the remainder cause pulmonary infarction.
2) Risk for recurrence is high

32
Q

Pulmonary HTN:
1) Define and describe it
2) What are the initial Sx?
3) What are the chronic Sx?

A

1) Pressures of 25 mm Hg or more at rest; decrease in the cross-sectional area of the pulmonary vascular bed or, less commonly, by increased pulmonary vascular blood flow.
2) Dyspnea and fatigue
3) Respiratory distress, cyanosis, and RVH

33
Q

WHO classification of HTN:
What is the definition? What are the 4 groups of causes?

A

Affecting small pulmonary muscular arterioles; i.e. connective tissue diseases, HIV, and congenital heart disease (left to right shunts)
1) Pulmonary hypertension due to left-sided heart disease,including systolic and diastolic dysfunction and valvular disease
2) Pulmonary hypertension due to lung diseases and/or hypoxia,including COPD, interstitial lung disease, and sleep apnea
3) Chronic thromboembolic pulmonary hypertension
4) Pulmonary hypertension with unclear or multifactorial mechanisms

34
Q

1) Define pneumonia
2) How many deaths in the US?

A

1) Any infection in the lung
2) One-sixth of all deaths in the U.S.

35
Q

List the 7 types of pneumonia

A

1) Community Acquired Bacterial Pneumonia
2) Community Acquired Viral Pneumonia
3) Nosocomial Pneumonia (hospital acquired)
4) Aspiration Pneumonia
5) Chronic Pneumonia
6) Necrotizing Pneumonia & Lung Abscess
7) Pneumonia of the Immunocompromised patient

36
Q

Acute Pneumonias:
1) What is the most common cause?
2) What do they involve?
3) List some characteristics

A

1) S. pneumoniae(the pneumococcus) is the most common cause of community-acquired bacterial pneumonia and usually has a lobar pattern of involvement.
2) Morphologically, lobar pneumonias involve an entire lobe and are bound by fissure lines.
3) Congestion: Lung is heavy, boggy, and red.
Red Hepatization: Massive confluent exudation as neutrophils, red cells and fibrin fill the alveolar spaces
Resolution: exudate broken down by enzymatic activity

37
Q

What are the clinical features of acute pneumonias?

A

1) Onset is usually abrupt
2) Often follows an upper respiratory tract infection
3) Systemic signs of infection: high fever, shaking chills, pleuritic chest pain
4) Local signs of irritation: productive mucopurulent cough
5) Airway obstruction: shortness of breath (dyspnea), rapid breathing (tachypnea)
6) Occasional patients may have hemoptysis

38
Q

1) World’s foremost cause of death from a single infectious agent is what?
2) What is the etiology of this Dx? How is it transmitted?

A

1) TB
2) Mycobacterium tuberculosis (rod-shaped bacterium with waxy capsule); airborne

39
Q

TB:
1) Is it communicable? Explain
2) What organ(s) are involved?

A

1) A communicable chronic granulomatous disease; centers of tubercular granulomas undergo caseous necrosis
2) Usually involves lungs, but may affect any organ

40
Q

Primary Pulmonary Tuberculosis:
1) What is it? Describe it
2) How common is it?

A

1) Primary infection in previously unexposed unsensitized patient
Localized infection in lung and regional lymph nodes
Ghon complex heals spontaneously by calcification and scarring
2) Progressive primary TB rare, only 5% newly infected acquire significant disease (mainly children, immunosuppressed individuals)

41
Q

1) Secondary tuberculosis can result from what 2 things?
2) What are its typical characteristics?

A

1) Dormant primary infection or a re-infection by M. tuberculosis
2) Bacteria typically spread to apex of lungs, causing granulomatous bronchopneumonia
-Confluent granulomas produce cavities

42
Q

Secondary Pulmonary Tuberculosis:
1) Pulmonary cavities are sources of what?
2) Tissue destruction ensues, and occasional bacterial spread. What are 3 potential conditions that can result from this?

A

1) Hemoptysis
1) Tuberculous pneumonia, Extrapulmonary tuberculosis, or Miliary tuberculosis (system wide)

43
Q

Both progressive primary tuberculosis and secondary tuberculosis can result in what? What does this cause?

A

1) Systemic seeding
2) Life-threatening forms of disease such as miliary tuberculosis and tuberculous meningitis.

44
Q

What is an important risk factor for the development or recrudescence of active tuberculosis?

A

HIV-seropositive status.

45
Q

Secondary tuberculosis
1) Usually occurs where?
2) Sx?
3) What is needed to Dx? How is it definitively established?

A

1) Secondary tuberculosis-usually in the apices
2) Nonproductive cough, low-grade fever, loss of appetite, malaise, night sweats, weight loss, hemoptysis
Chest X-rays essential for diagnosis
3) By identifying bacilli in sputum by acid-fast stains

46
Q

1) What is the most important cause of cancer related deaths in industrialized countries, that is also the leading cancer killer in men and women in U.S?
2) What is the most important risk factor?
3) At diagnosis, ___% of people have distant mets
4) Describe the survivability of this condition.

A

1) Carcinomas of the Lung
2) Smoking
3) 50%
4) Five-year survival rate is 16%, but is 45% for cases detected when the disease is still localized (within the lungs)

47
Q

What are the four major histologic subtypes of lung carcinoma?

A

1) Adenocarcinoma (most common)
2) Squamous cell carcinoma
3) Small-cell carcinoma (sub-type of neuroendocrine tumor)
4) Large-cell carcinoma

48
Q

Clinical Features of Lung Cancer:
1) Initial Sx?
2) Subsequent Sx (w. poor prognosis)?
3) Symptoms of metastatic spread can be presenting complaint, like what?

A

1) Cough & expectoration
2) Hoarseness
Chest pain
Superior vena cava syndrome
Pericardial or pleural effusions
3) Brain- mental or neurologic changes
Liver – hepatomegaly
Bone-pain

49
Q

Malignant Mesothelioma:
1) What is it?
2) What is it highlight related to?
3) What is the latent period? What is it secondary to?
4) Describe why it occurs

A

1) Rare CA of the mesothelial cells of visceral or parietal pleura
2) Airborne asbestos (80-90%)
3) From exposure to development = 25-40 years; secondary to causative driver mutations
4) Once inhaled, asbestos fibers remain for live and do not diminish over time (as with cessation of smoking)

50
Q

Pleural effusions:
Differentiate between transudate and exudate

A

1) Transudate → “hydrothorax”
-Most common cause: CHF
2) Exudate → defined as protein >30 g/L
-Microbial invasion (direct extension of pulmonary infection or blood-borne seeding)
-Cancer: ie lung carcinoma, metastatic neoplasms, mesothelioma
-Pulmonary infarction
-Viral Pleuritis

51
Q

Cystic fibrosis:
1) What is CF?
2) What is affected by the disease?

A

1) An autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
2) The CFTR protein chloride channel located in the apical membrane of the epithelial cells (lung, pancreas, sweat gland, vas deferens)

52
Q

1) The major features of classic cystic fibrosis are what 2 things?
2) Although CF has been observed in all races, it is predominantly a disease of what group?

A

1) Chronic pulmonary disease and malabsorption
2) Northern Europeans, with an incidence of approximately 1 in 2500 Caucasian births

53
Q

Pathogenesis of CF:
1) What does the CFTR protein do?
2) What happens in CF pts?

A

1) Maintains the hydration of secretions within the airways and ducts through the transport of chloride across the cell membrane and inhibition of sodium uptake
2) The chloride channel is unable to open causing chloride ions to accumulate in the cell. To balance the chloride ions, the cells absorb excess sodium. In secretory glands, this leads to decreases in fluid production.

54
Q

CF pathogenesis:
1) Loss of CFTR chloride transport into the pancreatic duct impairs what? What does this lead to? Explain.
2) What follows all of this?

A

1) Hydration of secretions and leads to the retention of exocrine enzymes in the pancreas. Damage from these retained enzymes eventually causes fibrosis of the pancreas.
2) Without proper pancreatic enzyme action, malabsorption follows

55
Q

CF pathogenesis:
1) CFTR also regulates the uptake of what?
2) What happens when the uptake can’t happen because of a non-functional CFTR?

A

1) Sodium and chloride from sweat as it moves through the sweat duct
2) The sweat has an increased sodium chloride content, and this is the basis of the historical “salty baby syndrome” and the diagnostic sweat chloride test

56
Q

CF Phenotype and Natural History:
1) CF classically manifests in early childhood, although approximately ___% of patients are diagnosed in adulthood.
2) At birth, most infants present with what? Describe.
3) CF patients have poor growth; why?

A

1) 4%
2) Most present w. chronic respiratory complaints; 15-20% present with meconium ileus due to thickened meconium or failure to pass meconium
3) Combination of increased calorie expenditure because of chronic lung infections and malnutrition from pancreatic exocrine insufficiency

57
Q

CF:
1) More than _____% of male patients with CF are azoospermic because of congenital bilateral absence of the vas deferens (CBAVD).
2) What is the chief determinant of morbidity and mortality?
3) The current average survival is ___ years of age in the United States

A

1) 95%
2) The progression of lung disease
3) 37

58
Q

CF Phenotype and Natural History:
1) A correlation between particular CFTR mutant alleles and disease severity exists only for what?
2) What markedly worsen the severity of lung disease among patients with CF?

A

1) Pancreatic insufficiency
2) Environmental factors (like exposure to cigarette smoke)

59
Q

How can CF be managed? (both lung and pancreatic Sx)

A

1) Pulmonary physical therapy and use of bronchodilators, antibiotics, and mucolytic agents to manage pulmonary disease
2) In those with pancreatic insufficiency, oral enzyme replacement is provided

60
Q

CF Inheritance Risk:
1) Two heterozygous carrier parents have a ____% risk of having a child with cystic fibrosis.
2) The heterozygous carrier frequency in the White population is approximately what?
3) There are newborn screenings for cystic fibrosis where?
Explain

A

1) 25% risk of having a child with cystic fibrosis
2) 1 in 50
3) All 50 states
-In many regions, carrier screening is provided based on detection of the most common CFTR mutations